UBS’s stock is now worth buying, after tumbling following the Swiss banking giant’s fourth-quarter earnings report, Deutsche ...

Net new money at Pictet fell last year to 11 billion Swiss francs ($12 billion), a decline of around 31% from the previous ...

Explore why the USD/CHF pair may continue to rise, and what to expect in the coming months amid the Fed and SNB divergence ...

Comparing the local index and dollar returns, the two diverge in some parts of the world, and the reason for the divergence ...

The Swiss franc could appreciate in coming months as the Swiss National Bank is unlikely to return to negative interest rates ...

KfW became the 14th SSA issuer to visit the Swiss franc bond market this year on Thursday, ending a 15 year absence from the currency. While the German agency is no stranger to funding outside its ...

The Swiss franc was flat, but its safe-haven credentials suggest further strength, and if the eurozone comes under pressure from internal politics or a trade war with the U.S. EUR/CHF could fall to 0.

YinYang/istockphotoWhen it comes to money, we tend to think that the U.S. dollar reigns supreme. But there are a handful of ...

Some fear snakes, while others are fascinated by these sleek reptiles. And the watch industry? It delves into the rich ...

Julius Baer will present a strategy update, including new medium-term targets, ahead of summer 2025. More details, including exact timing and venue, are expected to be communicated together with the ...

The Swiss Alps are attracting a growing number of investors, prepared to pump hundreds of millions of francs into vast tourist complexes. But at what cost?

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics ...